Publications

Our scientific publications in high-quality journals reflect the quality of the innovative research in Entasis’ laboratories.

Search by Program

Iyer R, Moussa S, Tommasi R, and Miller A

Role of the Klebsiella pneumoniae TolC porin in antibiotic efflux

Research in Microbiology (2019)

Taylor SN, Marrazzo J, Batteiger BE, Hook EW, Seña AC, Long J, Wierzbicki MR, Kwak H, Johnson SM, Lawrence K, and Mueller J

Single-dose zoliflodacin (ETX0914) for treatment of urogenital gonorrhea

New England Journal of Medicine (2018)

O' Donnell J, Lawrence K, Vishwanathan K, Hosagrahara V, and Mueller JP

Single-dose pharmacokinetics, excretion, and metabolism of zoliflodacin, a novel spiropyrimidinetrione antibiotic, in healthy volunteers

Antimicrobial Agents and Chemotherapy (2018)

Cristillo AD, Bristow CC, Torrone E, Dillon J, Kirkcaldy RD, Dong H, Grad YH, Nicholas RA, Rice PA, Lawrence K, Oldach D, Shafer WM, Zhou P, Wi TE, Morris SR, and Klausner JD

Antimicrobial resistance in Neisseria gonorrhoeae: proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting

Sexually Transmitted Diseases (2019)

Rodvold KA, Gotfried MH, Isaacs RD, O'Donnell JP, and Stone E

Plasma and intrapulmonary concentrations of ETX2514 and sulbactam following intravenous administration of ETX2514SUL to healthy adult subjects

Antimicrobial Agents and Chemotherapy (2018)

Tommasi R, Iyer R, and Miller A

Antibacterial drug discovery: some assembly required

ACS Infectious Diseases (2018)

Iyer R, Moussa S, Durand-Réville T, Tommasi R, and Miller A

Acinetobacter baumannii OmpA is a selective antibiotic permeant porin

ACS Infectious Diseases (2018)

McLeod SM, Shapiro AB, Moussa SH, Johnstone M, McLaughlin RE, de Jonge BLM, and Miller AA

Frequency and mechanism of spontaneous resistance to sulbactam combined with the novel β-lactamase inhibitor ETX2514 in clinical isolates of Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy (2018)